ESGO/INCIP Guidelines for the management of patients with gynecological cancers during pregnancy

ESGO–INCIP Guidelines on Gynecological Cancers During Pregnancy

Managing gynecological cancers in pregnancy is one of the most complex challenges in oncology. To support patients and healthcare teams, ESGO—together with the International Network on Cancer, Infertility and Pregnancy (INCIP)—has developed comprehensive, evidence-based guidelines.

These guidelines, first published in 2019 and recently updated, bring together the expertise of 21 international specialists, patient advocates, and 100 external reviewers worldwide. They provide practical algorithms and recommendations covering:

  • Safe diagnostic imaging and pathology during pregnancy

  • Surgical decision-making and timing

  • Systemic therapy and radiation considerations

  • Obstetric management and maternal–fetal follow-up

  • Patient perspectives and psychological support

  • Pediatric and long-term child outcomes

The guidelines ensure that every decision is grounded in the latest evidence and shaped by a truly multidisciplinary, global perspective.

25_WEB_ESGO-INCIP_1080x1350

Upcoming Webinar – January 6, 2026

To help clinicians translate these recommendations into practice, ESGO and INCIP are launching the new year with a dedicated interactive webinar:

Date: January 6, 2026
Time: 18:00 CET
Format: 90 minutes, with case presentations, expert lectures, polls, and live panel discussions

Join the guideline chairs and international experts as they walk through real-life cases, explore diagnostic and treatment pathways across trimesters, and discuss how to optimize care for both mother and child.

This is your opportunity to:

  • Learn directly from the guideline authors
  • Gain practical tools for multidisciplinary care
  • Ask questions and engage in interactive discussions
Time (CET) Session Speaker
18:00–18:05 Welcome & Housekeeping Notes Christianne Lok
18:05–18:15 Background and Imaging Paul Berveiller / Estelle Heggarty
18:15–18:20 Q&A / Discussion
18:20–18:30 Treatment Modalities Michael Halaska
18:30–18:35 Q&A / Discussion
18:35–18:45 Obstetric and Child Follow-up Frederic Amant
18:45–18:50 Q&A / Discussion
18:50–19:00 Patient Perspective Anne de Middelaer
19:00–19:20 Panel Discussion All speakers
19:20–19:25 Final Questions & Take-Home Messages Christianne Lok
19:25–19:30 Closing Remarks Michael Halaska & Frederic Amant